These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
485 related items for PubMed ID: 11032809
1. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. Holmström TH, Schmitz I, Söderström TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE. EMBO J; 2000 Oct 16; 19(20):5418-28. PubMed ID: 11032809 [Abstract] [Full Text] [Related]
2. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. Söderström TS, Poukkula M, Holmström TH, Heiskanen KM, Eriksson JE. J Immunol; 2002 Sep 15; 169(6):2851-60. PubMed ID: 12218097 [Abstract] [Full Text] [Related]
3. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
4. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, Faller DV. Cell Growth Differ; 2001 Jun 15; 12(6):297-306. PubMed ID: 11432804 [Abstract] [Full Text] [Related]
5. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043 [Abstract] [Full Text] [Related]
6. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P. Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748 [Abstract] [Full Text] [Related]
7. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH. Eur J Immunol; 1997 May 01; 27(5):1207-12. PubMed ID: 9174612 [Abstract] [Full Text] [Related]
8. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL. Alcouffe J, Therville N, Ségui B, Nazzal D, Blaes N, Salvayre R, Thomsen M, Benoist H. FASEB J; 2004 Jan 01; 18(1):122-4. PubMed ID: 14630709 [Abstract] [Full Text] [Related]
9. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Belka C, Marini P, Lepple-Wienhues A, Budach W, Jekle A, Los M, Lang F, Schulze-Osthoff K, Gulbins E, Bamberg M. Oncogene; 1999 Sep 02; 18(35):4983-92. PubMed ID: 10490833 [Abstract] [Full Text] [Related]
10. Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. Varadhachary AS, Peter ME, Perdow SN, Krammer PH, Salgame P. J Immunol; 1999 Nov 01; 163(9):4772-9. PubMed ID: 10528176 [Abstract] [Full Text] [Related]
11. Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation. Wang X, Zhang J, Kim HP, Wang Y, Choi AM, Ryter SW. FASEB J; 2004 Dec 01; 18(15):1826-33. PubMed ID: 15576486 [Abstract] [Full Text] [Related]
12. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H, Bamberg M, Budach W, Schulze-Osthoff K. Oncogene; 2000 Feb 24; 19(9):1181-90. PubMed ID: 10713706 [Abstract] [Full Text] [Related]
13. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation. Amanullah A, Liebermann DA, Hoffman B. Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589 [Abstract] [Full Text] [Related]
14. p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. Tourian L, Zhao H, Srikant CB. J Cell Sci; 2004 Dec 15; 117(Pt 26):6459-71. PubMed ID: 15572410 [Abstract] [Full Text] [Related]
15. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism. Gajate C, An F, Mollinedo F. Clin Cancer Res; 2003 Apr 15; 9(4):1535-45. PubMed ID: 12684430 [Abstract] [Full Text] [Related]
16. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. Strauss G, Knape I, Melzner I, Debatin KM. J Immunol; 2003 Aug 01; 171(3):1172-82. PubMed ID: 12874203 [Abstract] [Full Text] [Related]
17. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G. Arthritis Rheum; 2004 Feb 01; 50(2):498-506. PubMed ID: 14872492 [Abstract] [Full Text] [Related]
18. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways. Belka C, Gruber C, Jendrossek V, Wesselborg S, Budach W. Oncogene; 2003 Jan 16; 22(2):176-85. PubMed ID: 12527887 [Abstract] [Full Text] [Related]
19. Inhibition of Fas-induced apoptosis by Bcl-2. Kawahara A, Kobayashi T, Nagata S. Oncogene; 1998 Nov 19; 17(20):2549-54. PubMed ID: 9840917 [Abstract] [Full Text] [Related]
20. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma. Alas S, Ng CP, Bonavida B. Clin Cancer Res; 2002 Mar 19; 8(3):836-45. PubMed ID: 11895917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]